TB and COVID-19: paying attention to diabetes mellitus Article Swipe

PDF

Related Concepts

Coronavirus disease 2019 (COVID-19) Diabetes mellitus 2019-20 coronavirus outbreak Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Medicine Betacoronavirus Virology Pandemic Coronavirus Infections Intensive care medicine Internal medicine Outbreak Infectious disease (medical specialty) Disease Endocrinology

Anthony Harries , Ajay Kumar , Srinath Satyanarayana , Yan Lin , R. A. Dlodlo , Mohammed Khogali , Rony Zachariah , Anil Kapur ·

YOU? · · 2021 · Open Access · · DOI: https://doi.org/10.1093/trstmh/trab035 · OA: W3165402658

In 2019, global diabetes prevalence was 463 million. Diabetes increases the risk of TB and adverse treatment outcomes including death and relapse. Diabetes also increases the risk of severe disease, multi-organ failure, coagulopathy and death in COVID-19. TB and COVID-19 share many features, suggesting opportunities to integrate prevention, diagnosis and care. Three areas for further work are highlighted: better infection control in diabetes clinics, easier and quicker diagnosis using similar technology platforms and optimal blood glucose control. The funding and resources for COVID-19 should be harnessed to improve TB and diabetes care and achieve their respective sustainable development goal targets.